Zobrazeno 1 - 10
of 19
pro vyhledávání: '"E A Stadnik"'
Autor:
Yu V Mirolyubova, E A Stadnik
Publikováno v:
Современная онкология, Vol 20, Iss 1, Pp 17-22 (2018)
The determination of the minimal residual disease (MRD) in chronic lymphocytic leukemia (CLL) has acquired significance in connection with the success of therapy for this disease. Immunochemotherapy regimens significantly prolonged the life of CLL pa
Externí odkaz:
https://doaj.org/article/ce24d89a085741bdaa0176e0bd5bf6ee
Autor:
E A Stadnik, V V Strugov, T O Andreeva, Yu V Virts, A M Rumyantsev, Yu V Mirolyubova, P A Butylin, A Yu Zaritsky
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 57-64 (2017)
Aim. To evaluate the efficacy and safety of the BR regimen containing bendamustine in patients with chronic lymphocytic leukemia (CLL) who have not previously received specific therapy. Subjects and methods. The results of the Russian prospective obs
Externí odkaz:
https://doaj.org/article/cd650e21d2374da8a7d8ff39b67fd7cc
Autor:
E A Stadnik, V V Strugov, T O Andreeva, Yu V Virts, Yu V Mirolyubova, P A Butylin, A Yu Zaritskiy
Publikováno v:
Современная онкология, Vol 18, Iss 5, Pp 33-35 (2016)
This trial has evaluated a systematic prospective analysis of the efficacy and safety of BR in CLL patients in the routine clinical practice. It included 179 patients with verified CLL diagnosis and the presence of the indications for initiation of t
Externí odkaz:
https://doaj.org/article/e9d31cf4381f45f4a0418436c5ced9c6
Autor:
E A Nikitin, M Hallek, V V Baykov, B A Bakirov, S S Bessmel'tsev, T P Zagoskina, A M Kovrigina, T S Konstantinova, Yu A Krivolapov, S A Lugovskaya, A E Matsionis, T N Obukhova, E A Osmanov, T I Pospelova, O S Samoylova, E A Stadnik, N N Tupitsyn, Yu V Shatokhin, I V Poddubnaya
Publikováno v:
Современная онкология, Vol 14, Iss 4, Pp 10-14 (2012)
Externí odkaz:
https://doaj.org/article/80b97486458346a083d943846502eb41
Publikováno v:
Современная онкология, Vol 13, Iss 2, Pp 26-30 (2011)
Externí odkaz:
https://doaj.org/article/6932bc0ae9af414f885c78e235bbe15f
Autor:
E A Stadnik, E A Nikitin, B V Biderman, G N Salogub, Yu Yu Lorie, N N Tsyba, Yu A Alekseeva, V A Doronin, V N Mashchuk, R I Vabishchevich, A L Melikyan, T I Kolosheynova, L Yu Kolosova, A B Sudarikov, L G Kovaleva, A Yu Zaritskiy
Publikováno v:
Современная онкология, Vol 10, Iss 3, Pp 60-64 (2008)
В-клеточный хронический лимфолейкоз (В-ХЛЛ) – самый частый вид лейкозов взрослых, остается неизлечимым заболеванием у подавляющего бол
Externí odkaz:
https://doaj.org/article/8547acd1ce73401ebdb6bb9449262727
Autor:
E. A. Nikitin, T. E. Bialik, A. Iu. Zaritskii, L. Iseber, K. D. Kaplanov, T. N. Lopatkina, S. A. Lugovskaia, O. V. Mukhortova, E. A. Osmanov, I. V. Poddubnaya, O. S. Samoilova, E. A. Stadnik, N. A. Falaleeva, V. V. Baikov, A. M. Kovrigina, A. A. Nevol’skikh, S. A. Ivanov, Zh. V. Khailova, T. G. Gevorkian
Publikováno v:
Современная онкология, Vol 22, Iss 3, Pp 24-44 (2020)
Chronic lymphocytic leukemia/small lymphocytic lymphoma. Clinical recommendations
Externí odkaz:
https://doaj.org/article/0f3917e46f764e658e649fc6cb727659
Autor:
A. V. Rudakova, E. A. Stadnik
Publikováno v:
Онкогематология, Vol 15, Iss 1, Pp 73-82 (2020)
Background. Currently, treatment of recurrent / refractory chronic lymphocytic leukemia (CLL) involves the appointment of regimens with innovative drugs, which include ibrutinib and a combination of venetoclax and rituximab. Wherein said combination
Externí odkaz:
https://doaj.org/article/bca311d490134ae49902edaccfa259b6
Publikováno v:
Онкогематология, Vol 12, Iss 4, Pp 18-26 (2018)
Currently we are facing a revolution in therapy of chronic lymphocytic leukemia, related to the development of novel target drugs, which have markedly improved treatment results in all groups of patients. While inhibitors of Bruton’s tyrosine kinas
Externí odkaz:
https://doaj.org/article/0515099d9c794a59b7b3bae78f03019c
Autor:
D. A. Perehodko, E. A. Stadnik
Publikováno v:
Kharkiv Surgical School. :70-73
Resume. In this work we introduce the results of examination of 35 patients with neoplasia of distal part of colon. During this examination we use a system of fotodynamic diagnostic SFD.M16-1C2 and a pharmacological drug Hyperflav. Endoscopic examina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1da2a7b33a3e1edf27b27da839d15f00
https://doi.org/10.37699/2308-7005.5-6.2019.15
https://doi.org/10.37699/2308-7005.5-6.2019.15